EC Calls for Applications: Implementation research/real life assessment of existing interventions in women and children’s health grant

The EC is inviting applications for the Implementation research/real life assessment of existing interventions in women and children’s health grant.

In countries in SSA, infectious diseases remain the leading causes of morbidity and mortality, especially during pregnancy and childhood. Because of limited evidence on the contribution of these diseases to maternal and neonatal mortality, the importance of PRDs for maternal, foetal, and neonatal deaths is often poorly recognised. Despite the progress made in other age groups, effective treatment and prevention of PRDs and other diseases such as diarrhoeal diseases, bacterial infections (especially those where antimicrobial resistance is an issue), sepsis and lower respiratory tract infections in mothers, newborns and children is often lacking and/or lagging. The frequent exclusion of pregnant women and children from clinical trials and the limited number of available products targeting these groups, are factors that contribute to the lowest health indicators in these vulnerable populations. In addition, there is a need for critical appraisal of existing health interventions, which may have been introduced and used by healthcare systems without rigorous evaluation in clinical trials. It is thus important to understand whether such interventions lead to better overall health in these populations.

This call is restricted to the following diseases: HIV, malaria, tuberculosis, diarrhoeal diseases, bacterial infections (especially those where antimicrobial resistance is an issue), sepsis and lower respiratory tract infections.

Read more here.

Application deadline June 29, 2023.